Duke Early Phase Clinical Research Unit - PPDS — Durham, North Carolina

Duke Early Phase Clinical Research Unit - PPDS is a clinical research site located in Durham, North Carolina, United States 27710-0001.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Early Phase Clinical Research Unit - PPDS has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Sjögren's Syndrome (SS), Sjögren's Syndrome, Sjogren's Syndrome.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Early Phase Clinical Research Unit - PPDS?

Duke Early Phase Clinical Research Unit - PPDS has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Early Phase Clinical Research Unit - PPDS conducted?

Duke Early Phase Clinical Research Unit - PPDS has 3 clinical trials on record, with 3 currently active. Their work covers Sjögren's Syndrome (SS), Sjögren's Syndrome, Sjogren's Syndrome.

Is Duke Early Phase Clinical Research Unit - PPDS accredited by Crixeo Health?

Duke Early Phase Clinical Research Unit - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Early Phase Clinical Research Unit - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.